Publications
-
Kobialka P, Sabata H, Vilalta O, Gouveia L, Angulo-Urarte A, Muixí L, Zanoncello J, Muñoz-Aznar O, Gene-Olaciregui N, Fanlo L, Esteve-Codina A, Lavarino C, Javierre BM, Celis-Passini V, Rovira-Zurriaga C, López-Fernández S, Baselga E, Mora J, CastilloSD and Graupera M.
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
EMBO Molecular Medicine . 14(7): . Number of citations: 34
-
Diociaiuti A, Baselga E, Boon LM, Dompmartin A, Dvorakova V, El Hachem M, Gasparella P, Haxhija E, Ghaffarpour N, Kyrklund K, Irvine AD, Kapp FG, Rößler J, Salminen P, van den Bosch C, van der Vleuten C, Kool LS and Vikkula M.
The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas
EUROPEAN JOURNAL OF MEDICAL GENETICS . 65(6): 104517-104517. Number of citations: 3
-
Wollenberg, A, Marcoux, D, Silverberg, JI, Aoki, V, Baselga E, Zhang, HX, Levit, NA, Taieb, A and Rossi, AB.
Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
ACTA DERMATO-VENEREOLOGICA . 102: . Number of citations: 5
-
Carrascosa Carrillo JM, Baselga E, Gilaberte Calzada Y, Jurgens Martínez YN, Roustan Gullón G, Yanguas Bayona JI, Gómez Castro S, Ferrario MG and Rebollo Laserna FJ.
Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment
Dermatology and Therapy . 12(5): 1197-1210. Number of citations: 8
-
Douzgou S, Rawson M, Baselga E, Danielpour M, Faivre L, Kashanian A, Keppler-Noreuil KM, Kuentz P, Mancini GMS, Maniere MC, Martinez-Glez V, Parker VE, Semple RK, Srivastava S, Vabres P, de Wit MY, Graham JM Jr, Clayton-Smith J, Mirzaa GM and Biesecker LG.
A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement
CLINICAL GENETICS . 101(1): 32-47. Number of citations: 28
-
Iznardo H, Bredrup C, Bernal S, Gladkauskas T, Mascaró JM Jr, Roé E and Baselga E.
Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome
AMERICAN JOURNAL OF MEDICAL GENETICS PART A . 188(4): 1233-1238. Number of citations: 6
-
Baselga E, El Hachem M, Diociaiuti A, Carnevale C, Downey C, Roe E, Mascaro P, Neri I, Leuzzi M, Bernabeu-Wittel J, Monserrat-García MT, Ortiz-Prieto A, Torrelo A, Knopfel N, Vercellino N, Manunza F, Oranges T, Bassi A, González-Enseñat MA, Vicente-Villa MA, Gich I and Puig L.
Sequelae following infantile haemangiomas treated with propranolol
EUROPEAN JOURNAL OF DERMATOLOGY . 31(6): 785-790. Number of citations: 6
-
Cuenca-Barrales C, Baselga E, Del Boz-González J, Vicente-Villa MA, Palencia-Pérez SI, Campos-Domínguez M, Valdivieso-Ramos M, Martín-Santiago A, Montserrat-García MT, Azón-Masoliver A, Feito-Rodríguez M, Domínguez-Cruz JJ, Roé-Crespo E, Salas-Márquez C, Giacaman A, Lorente-Lavirgen AI, Quintana-Castanedo L, de Vega-Martínez M, García-Doval I and Bernabéu-Wittel J.
Baseline Description of the Spanish Academy of Dermatology Infantile Haemangioma Nationwide Prospective Cohort. Comparison of Patients Treated with Propranolol in Routine Clinical Practice with Previous Pivotal Clinical Trial Data
ACTAS DERMO-SIFILIOGRAFICAS . 112(9): 806-816. Number of citations: 3
-
Holm A, Te Loo M, Schultze Kool L, Salminen P, Celis V, Baselga E, Duignan S, Dvorakova V, Irvine AD, Boon LM, Vikkula M, Ghaffarpour N, Niemeyer CM, Rössler J and Kapp FG.
Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network
Frontiers in pediatrics . 9: 697960-697960. Number of citations: 8
-
Rusiñol L, Amat-Samaranch V, Baselga E, Puig L and Roé E.
Prepubertal retroareolar cysts
PEDIATRIC DERMATOLOGY . 38(5): 1368-1369. Number of citations: 1